Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

AstraZeneca Signs MOU to Become Founding Partner of Life Science Park in Wuxi, China

publication date: Mar 29, 2019

AstraZeneca signed a Memorandum of Understanding with Wuxi High-tech District to become a Founding Partner of a new life sciences park located in Wuxi, China. The new park will provide startup companies with shared resources, including laboratories, equipment and services. In addition, AstraZeneca will offer its global R&D network to support end-to-end development and commercialization of medicines. AstraZeneca said the International Life Science Innovation Park will bring together local and international companies, government and medical/academic institutions. More details....

Stock Symbol: (NYSE: AZN)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital